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ABSTRACT 
Objective: To establish correlations between risk factors for prostate cancer. Method: 155 Medical records of patients 
with prostate cancer were analyzed regarding the tumor characteristics and risk factors. Results: The patients on 
average were 70 years of age, incomplete grade school (70%), exposed to pesticides (68.56%), non-smokers (93.8%), 
and alcohol consumption (71.2%), patients with adenocarcinoma (98.71%) and metastases (12.90%). Positive 
correlations (0.001) were evidenced with occupational exposure (r= 0.588), use of medications (r= 0.569) and radiation 
exposure (r= 0.609). No correlations were observed for diet, smoking and alcoholism. Conclusion: The data show that 
for associations between genetic factors and occupational exposure, with emphasis to the mutagenicity and 
carcinogenicity. Descriptors: Prostate cancer, Risk factors, Mutagenicity, Carcinogenicity. 
 
RESUMO 
Objetivo: Estabelecer correlações entre fatores de risco para o câncer de próstata. Método: 155 prontuários de 
pacientes com câncer de próstata foram analisados quanto às características do tumor e aos fatores de risco. 
Resultados: Os pacientes apresentavam em média 70 anos de idade, primário incompleto (70%), expostos a agrotóxicos 
(68,56%), sem hábitos para tabagismo (93,8%), e etilismo (71,2%), portadores de adenocarcinoma (98,71%) e metástases 
(12,90%). Correlações (0,001) positivas foram evidenciadas com exposição ocupacional (r=0,588), uso de medicamentos 
(r=0,569) e exposição a radiações (r=0,609). Não foram observadas correlações para dieta, tabagismo e etilismo. 
Conclusão: Os dados apontam para associações entre fatores genéticos e exposição ocupacional, com ênfase para a 
mutagenicidade e carcinogenicidade. Descritores: Câncer de próstata, Fatores de risco, Mutagenicidade, 
Carcinogenicidade. 
 
RESUMEN 
Objetivo: Establecer correlaciones entre los factores de riesgo para el cáncer de próstata. Método: 155 registros 
médicos de pacientes con cáncer de próstata fueron analizados por las características del tumor y los factores de 
riesgo. Resultados: Los pacientes tenían una edad mediana de 70 años, primaria incompleta (70%), expuesta a los 
pesticidas (68,56%), sin que el hábito de fumar (93,8%) y el consumo de alcohol (71,2%) que adenocarcinoma (98,71%) y 
metástasis (12,90%). Correlación (0.001) Correlación (0.001) positivas fueron observados con la exposición ocupacional 
(r=0,588), el uso de medicamentos (r=0,569) y la exposición a la radiación (r=0,609). No se observó la correlación con 
la dieta, el tabaquismo y consumo excesivo de alcohol. Conclusión: Los datos sugieren asociaciones entre los factores 
genéticos y la exposición ocupacional, con énfasis en la mutagenicidad y la carcinogenicidad. Descriptores: Cáncer de 
próstata, Factores de Riesgo, Mutagenicidad, Carcinogenicidad. 
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Cancer will be the main cause of 
mortality in the world in the coming decades. 
Associated with this forecast, cancer has a 
strong impact on society, a time that results in 
a public health problem, causing productive 
individuals disabilities that affect social and 
economic segments. 1 Since 2003, malignant 
neoplasms are the second cause of death in 
the population, representing almost 17% of 
deaths of known causes, notified in Mortality 
information System in 2007. It is estimated 
that, in 2030, the number of new cases per 
year in the world will be 27 million, of which 
approximately 60% occur in developing 
countries. In addition, 257,870 new cases will 
be expected, in 2013, for the males, and 
260,640 for females. In this context, it is 
estimated that most incidents will be non-
melanoma skin cancer (134,000 new cases), 
prostate (60,000), female breast (53,000), 
colon and rectum (30,000), lungs (27,000), 
stomach (20,000) and cervical (18,000).2  
Currently, it is known that at least one-
third of the new cases of cancer that occur 
every year in the whole world could be 
prevented. 3 Among these, the prostate cancer 
- one of the malignant neoplasms more 
frequent in the world and that further 
increases incidences in the male population in 
virtue of an extension in life expectancy, 
which estimates exceed 70 years, in Brazil, in 
2020. 4 Allied to this it is configured as the 
second leading cause of death in Brazil.5 
Prostate cancer is the second most 
common malignant neoplasm in men observed 
in different ethnic groups. The Americas and 
Africa has a high prevalence (137 cases per 
100,000 inhabitants), while in Asian 
populations, the prevalence is less than 10 
cases per 100,000 people. These data suggest 
that genetic factors may contribute to these 
differences in susceptibility. 6 However, a 
positive correlation with the family history has 
been recognized as one of the most important 
risk factors, as well as the age.7 More than any 
other cancer, this is considered a cancer of 
third age, since about three-quarters of the 
cases occur in the world after 65 years of 
age.8-9  
The early diagnosis signals a better 
prognosis for the patient that offers of 
therapies with chances of cure. 10 There are 
opportunities for the prevention of most 
cancers, because about 80-90% of them are 
related to lifestyle and environmental factors, 
some of which are well known, such as 
smoking, alcohol consumption, excessive 
exposure to ionizing radiation and sunlight, 
chemicals in food and other exposures to 
carcinogenic agents.11-12  
In this context, this study aims to 
examine the records of the Department of 
Health Statistics (SAME), in a Care Center for 
Cancer in the city of Teresina, Piaui, Brazil, in 
the period 2010/ 2012. With the objective of 
characterizing the socio-economic and clinical 
profiles of patients with prostate cancer, 
performing the mapping of probable risk 
factors associated with cancer, from 
information to patients undergoing 
chemotherapy and/or radiotherapy, as a 
strategy to improve the prevention of cancer 
in Piaui. 
INTRODUCTION 
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Characterizations of the study 
 
 The research was exploratory and 
descriptive, once that were observed facts, 
recorded, analyzed, classified and interpreted 
without the interference of the researcher, 
who sought to gather information about a 
particular object, delimiting, thus, a fieldwork 
and mapping the manifestation conditions of 
this object. With regard to procedures, the 
study was carried out by means of collecting 
data from medical records of patients with 
prostate cancer, as well as the application of a 
health questionnaire. 
 
Ethical Aspects 
 
 The research was carried out with the 
authorization of the direction of Hospital Sao 
Marcos and obeyed the resolution 466/12 of 
the National Council of Ethics, which regulates 
the operational issues and ethical scientific 
research involving human beings. The patients 
who agreed to participate in the study signed a 
Free and Informed Consent Term (FICT). The 
approval by the UNINOVAFAPI Research Ethics 
Committee is registered under the number 
0151.0.043.000-11. 
 
Data Collection and sample characterization 
 
 The health service chosen for the 
research was the Sao Marcos Hospital, which is 
a reference center for diagnosis and treatment 
of cancer in Teresina, Piauí. In addition it 
meets the population of several states of 
Brazil, especially the states of Maranhão, Pará, 
Ceará and Tocantins The database query aimed 
to identify which type of malignant tumor 
more present among patients, as well as the 
socio-economic aspects and clinical treated at 
the institution during the period of 2010/2012. 
We analyzed 155 medical records of patients 
with prostate cancer. Of these, 20 patients 
agreed to participate in the second stage of 
the research by responding to a questionnaire 
for public health in obeying the protocol 
published by the International Commission for 
Environmental Protection the Mutagens and 
Carcinogens (ICPEMC). 13 The questionnaire 
was applied after prior authorization of 
patients upon the signature of the Free and 
Informed Consent Form. Patients were 
excluded who did not undergo chemotherapy 
and/or radiotherapy, or didn't accept to 
participate in the research.  
 
Statistical analysis 
 
 For data analysis, the Spearman's test 
was used through the program SPSS 20.0 for 
correlation between potential risk factors in 
patients with prostate cancer and the analysis 
of variance (ANOVA) by the Tukey test, 
through the program Graph Pad Prism 5.0. 
 
 
  
 
According to epidemiological studies, 
carried out in the Sao Marcos Hospital, in the 
period 2010/2012, 155 patients with prostate 
cancer were recorded. The general 
METHODOLOGY 
 
 
RESULTS AND DISCUSSION 
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characteristics of the subjects are presented in 
Table 1. The data recorded in the medical 
records, as well as those reported by patients 
indicate that the majority of patients with 
cancer is brown ethnicity (43.8%), with 
incomplete elementary education (70%). The 
patients with prostate cancer, on average 
were 70 years of age. 
 
The data relating to clinical aspects are 
presented in Table 2, including the location of 
the cancer and their subtypes, as well as 
indicative of metastasis and clinical treatment. 
In their majority, the patients had 
adenocarcinoma and treatment focused on 
surgery and radiotherapy. The percentage of 
metastasis for prostate cancer was 12.9%. The 
implementation of mechanisms for monitoring 
treatment, in relation to the damage in normal 
cells, as well as for the process of angiogenesis 
is a strategy for the prevention of metastasis 
and new neoplasms. 
 
Currently, it is known that at least one-
third of all new cases of cancer that occur 
annually in the world could be avoided. 14-15,3 
This possibility to prevent many cancers is 
related to the fact that approximately 80-90% 
of them are related to environmental factors 
and the style of life, some of which are well 
known, such as smoking, alcohol consumption, 
excessive exposure to sunlight and the ionizing 
radiation, chemicals in foods, as well as 
occupational exposure to carcinogenic 
agents.11,16  
Until now, only three risk factors for 
prostate cancer has been well established: 
age, race and family history.8,17 In studies with 
animals, testosterone may induce the prostate 
cancer, acting as a promoter of genotoxicity, 
as well as estradiol, derived from 
testosterone, which can lead to DNA adducts, 
but also generates reactive oxygen species 
that lead to mutations.18  
Family history of prostate cancer 
presents significance representing a potential 
risk factor. Several lines of evidence indicate 
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that the human tumorigenesis is a process that 
involves several steps and these are reflected 
in genetic alterations that lead to the gradual 
transformation of human cells.19 Thus, the 
initiation and progression of carcinogenesis 
involving the accumulation of many 
mutations.20  
In Table 3 are presented the 
epidemiological data relating to the main risk 
factors identified in patients with prostate 
cancer. As noted, smoking and drinking habits 
of the patients are in focus. However, the diet 
low in micronutrients worrisome, as well as 
the question of the use of medicines without 
medical prescriptions. 
 
It is known that tobacco contains more 
than 4720 substances, 60 are known 
carcinogens: polycyclic aromatic hydrocarbons, 
nitrosamines, aromatic amines, aldehydes and 
volatile organic compounds and other metals. 
Such substances may produce DNA adducts 
that can cause damage to genetic material, 
contributing to the process of 
carcinogenesis.21,22  
The World Health Organization (WHO) 
considers smoking as the main cause of death 
that can be prevented in the world and a risk 
factor for cancer. According to the WHO, more 
than 5 million people die each year around the 
world due to smoking, being that the majority 
of these deaths are concentrated in people 
with low and medium incomes. It also shows 
that, in 2030, the number of deaths will 
exceed the home of 8 million, reaching one 
billion deaths by the end of this century. 
Smoking is a predictive cancer variable by 
inducing significant changes in genetic 
material, observed by cytogenetic biomarkers. 
23 The mechanism used by these factors to 
trigger the emergence of neoplasms is related 
to imbalance in production process and 
elimination of ERO, capable of damaging the 
DNA and compromising important genes in 
systems such as repair. 24 Tumor suppressor 
Genes such as p53 and PTEN when deregulated 
can lead to impairment of important functions 
such as apoptosis induction, activation of the 
repair system and cell cycle arrest.25 
Alcoholism has been associated with 
cancer of the esophagus, larynx, pharynx, but 
can also be a risk factor for prostate cancer. 
Although the ethanol is not a direct 
carcinogen, one of its metabolites, 
acetaldehyde, may act as a tumor promoter.26 
Alcohol abuse of shows synergy with chronic 
hepatitis B or an infection with the hepatitis C 
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virus, predisposing the body for the 
development of hepatocellular carcinoma.11  
Diets poor in micronutrients increases 
the risk of degenerative diseases, including 
cancer. 27-28 It is known that the vitamins and 
minerals are essential for the maintenance of 
genomic stability, in addition to exercise 
influence on the metabolism, in many aspects, 
including DNA synthesis, repair, the 
methylation and apoptosis. 28-30 
epidemiological Evidences indicate the 
protective factors, such as a diet rich in 
vitamin E, selenium, lycopene, soybeans and 
products made from milk and meat.31-32 
Obesity, low physical activity and low 
consumption of antioxidants, vitamin D and 
calcium, coffee are risk factors.33-34  
There are reports of carcinogenicity 
resulting from pharmaceutical drugs both in 
animals and in human beings with positive 
responses in several tests for genotoxicity, 
mutagenicity and carcinogenicity, with 
suggestions for a better assessment of the risks 
and benefits of medicines.35-36  
It is worth mentioning that the patients 
in this study also consume drugs not prescribed 
by doctors, with emphasis on analgesics and 
anti-inflammatory (Table 3). In most cases, the 
damage is repaired by the body, when it does 
occur, it can result in mutations that may be 
perpetuated into daughter cells during the 
replication process.37-38  
Oncologic therapy have evolved and 
reached achievements relevant as the 
development and implementation of 
antineoplastic agents that ensure a better 
prognosis for the patient. Although the 
benefits are unquestionable, we should not 
underestimate a profile that offers security, 
once again that these drugs cause imperiling 
effects on critical systems to interact with the 
DNA. 39-40 In chemotherapy, which has been 
used is the combined therapy, which consists 
in combinations of surgery, radiotherapy and 
chemotherapy, seeking to eradicate both the 
neoplasm primary as their occult 
micrometastases, before one can detect the 
occurrence of macroscopic distribution in the 
physical or radiological examination.41  
Numerous epidemiological studies have 
reported that, in most cases, the cancers are 
caused by continuous exposure to mutagenic 
and carcinogenic agents. Individual 
susceptibility may depend on the genetic 
predisposition, the differences in eating habits 
and lifestyle. The individual response to stress 
may vary according to conditions, such as the 
function and the particular combination of 
genes, absorption and metabolism, the cell 
death apoptosis/necrosis, cell cycle control, 
DNA repair and immune response and 
micronutrient deficiencies.41-42  
Thus, the identification of risk factors 
can contribute routinely in the diagnosis and 
treatment of patients with prostate cancer. 
Despite the lack of evidence of other factors, 
such as the consumption of alcohol, diseases, 
infections, exercise, the biomass body and 
genotypes may also influence the data 
interpretation. These analyzes are required for 
the consideration of genetic instability in 
studies of correlations between chemical 
exposure occupational and environmental.43 
The majority of cancer cases (80 %) are 
related to the environment, holding a large 
number of risk factors. It is understood as the 
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general environment (water, land and air), the 
occupational environment (chemical industries 
and related), the environment of consumption 
(food, medicines). Changes in the environment 
caused by man himself, the life style adopted 
by persons can determine different types of 
cancer.14-15  
In terms of occupation of the patients 
interviewed, approximately 70% are related to 
family farming or being active or retired 
farmers. The patients were also exposed to 
physical agents, such as the use of radiation in 
clinical diagnoses and treatments (Table 3).  
During the diagnosis and cancer therapy, 
humans are exposed to high linear energy 
transfer, which cause various biological 
effects, including inactivation of cells, genetic 
mutations, which can result in the induction of 
cancer.44 Despite of ionizing radiation have 
applicability medical and non-medical, 
constitute a threat to Human Health 
worldwide. Knowledge of their changes in gene 
expression of irradiated cells can be of 
paramount importance to establish paradigms 
for radiation protection45  
In addition, the exposure of the DNA 
molecule to radiation triggers a complex 
cascade of signal transduction causing damage 
to the genetic material. Recently, studies have 
demonstrated deletions and alterations in the 
genome with alterations in the expression of 
genes after exposure to delayed response 
radiation doses having malignant 
transformations in human fibroblasts. 45 
Therefore, ionizing radiation is known for its 
carcinogenicity potential.46  
 Chemical Agents that initiate 
carcinogenesis are extremely varied including 
both synthetic and natural products. 19 
exposure to pesticides (organochlorine 
pesticides, dioxins polychlorinated) can also be 
a risk factor associated with cancer.47 The 
occupational exposure to pharmaceutical 
products, herbicides and fungicides have been 
associated with the development of lung 
cancer.48,22  
As seen in Tables 3, numerous 
epidemiological aspects relating to risk factors 
such as the risks of self-medication, 
occupational exposure to pesticides were 
evidenced as predictors for prostate cancer; in 
addition to the importance of family history. 
To determine the correlations between the 
probable risk factors, the data were submitted 
to Spearman's statistical correlations.  
Table 4 shows positive correlations 
between the type of work, in their majority 
involved with agriculture with exposure to 
pesticides, medicines, exposure to X-Rays, 
family history and the patient with prostate 
cancer, with a factor of correlation of 0.588 
and significance level of 0.016 (p < 0.05). It 
must be emphasized that, in this occupational 
exposure, patients are exposed to various 
chemicals, potentially mutagenic.  
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No correlations were found between 
smoking and prostate cancer studied (Table 4). 
Although the literature does not record the 
specific association between smoking and 
prostate cancer, 49-52 recent studies suggest 
that the habit of smoking as a major risk factor 
for a considerable number of neoplasms in 
humans. 
Associations between smoking and 
cancer, due to the diversity of chemical 
products that comprise the tobacco, are 
considered as genotoxic and carcinogenic. 16,19 
Smoking is associated with the occurrence of 
several malignant diseases in the oral cavity, 
pharynx, esophagus, stomach, pancreas, colon, 
rectum, liver and biliary tract, kidneys, 
bladder, breast, cervix, vulva, myeloid 
leukemia, among others.21-22 Numerous 
evidences indicate an association between 
active and passive smokers with cancer. 
However, this correlation is not yet well 
established due to possible interactions 
between smoking, alcohol and influences of 
hormonal factors,50,52 one aspect that can also 
be found in the presented data. 
 In relation to the general characteristics 
of health, patients with prostate cancer 
reported the onset of cardiovascular diseases 
(62.5%), genetic (50%), bacterial infection 
(93.5%). However, it was observed that low 
percentage for hepatitis (6.45%), meningitis 
(6.45%) and mononucleosis (6.45%), in addition 
to other genetic diseases. It is worth 
emphasizing that, after application of the test 
of correlations were found significant 
statistical data for other diseases related to 
the development of prostate cancer (Table 5).  
 
Cardiovascular diseases and cancer are 
the leading causes of mortality in the world. 
Risk factors are smoking and diet, as well as 
the pathogenic processes, such as chronic 
inflammation and oxidative stress that cause 
genetic instability.28 
 
 
 
 
The notoriety of cancer as one of the 
main causes of death suggests the need for an 
in-depth approach to their intrinsic biological 
aspects of presentations and the risk factors 
involved in its etiology. In this light, this work 
extends the discussion on the main risk factors 
identified in patients diagnosed with prostate 
cancer. Age is well established as a risk factor 
for prostate cancer, whose prevalence is 
observed from 70 years of age forward, as 
shown in the literature. Age is associated with 
CONCLUSION 
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the risk factors from environmental and 
occupational for the study population.  
However, the positive correlations were 
also observed as family history. Taking into 
account the risks of genetic instability 
associated with DNA damage, another 
important aspect is correlated with 
environmental exposure and / or occupational 
reported by patients. The majority of patients 
with prostate cancer were farmers or retired 
as such. Significant exposure to pesticides can 
result in genomic instability that may trigger a 
carcinogenic process. A significant Percentage 
of patients with prostate cancer had a family 
history, especially father and grandfather. 
Other risk factors described in the literature 
are related to lifestyle, such as smoking and 
alcohol consumption that, in this study, were 
not correlated. However, the use of drugs, 
especially those prescribed by doctors can be 
mentioned as a risk factor.  
We should also emphasize that in the 
study in focus, nutrition was not associated 
with risk factors. However, other studies 
should be conducted due to the importance of 
micronutrients for genetic stability. 
Considering cancer as a multifactorial genetic 
disease, with strong influences of age, 
ethnicity, socioeconomic factors, lifestyle, 
family history, micronutrients and epigenetic 
factors associated with occupational and 
environmental risk, the findings obtained in 
this epidemiological study corroborate as the 
main risk factors that guide the etiology of 
prostate cancer. The results obtained can be 
used as indicators of public policies related to 
the treatment and prevention of prostate 
cancer. 
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